Spirometer Market Development Status by 2028
Spirometer |
A spirometer is a device that measures the amount of air
that enters and exits the lungs during breathing to determine lung capacity. In
a spirometer test, the patient inhales deeply into a spirometer tube connected
to a reader, which measures and records the lungs' air capacity. Any variation
from the typical spirometer readings shows that the lungs are dysfunctional.
Cystic fibrosis, pulmonary fibrosis, emphysema, chronic bronchitis, asthma,
bronchiectasis, and other chronic lung illnesses may all be diagnosed with a
spirometer.
The global Spirometer
Market is estimated to be valued at US$ 958.0 million in 2021
and is expected to exhibit a CAGR of 9.5% over the forecast period (2021-2028).
In the case of chronic pulmonary disorders, a spirometer can also be used to
practise breathing exercises and avoid the buildup of mucus and fluid in the
lungs. A spirometer can also be used to evaluate lung function before
undergoing surgery such as bariatric surgery, knee replacement surgery, or
other procedures.
Covid-19 Impact on
Spirometer Market
COVID-19 is a newly identified novel coronavirus that causes
an infectious sickness. On March 11, 2020, the World Health Organization (WHO)
proclaimed COVID-19 a pandemic. This pandemic has hampered economic growth in a
variety of sectors. Respiratory disorders are among the world's major causes of
mortality, accounting for five of the top 30. The third-leading cause of
mortality is chronic obstructive pulmonary disease (COPD). The COVID-19
epidemic has resulted in an upsurge in respiratory illness cases. The epidemic
has wreaked havoc on health-care systems across the world. There is expected to
be an increase in the number of ARDS patients who require respiratory
assistance, as well as a rise in the demand for spirometers.
The COVID-19 outbreak and subsequent lockdown in several
nations across the world has had a severe impact on enterprises in all
industries. The COVID-19 pandemic has had a significant influence on the
healthcare industry's whole supply chain, owing to stringent lockdown in
certain places. However, due to the need for techniques to give relief from
COVID-19 patients' breathing issues, the COVID-19 pandemic is projected to have
a favourable influence on the spirometer market in this COVID-19 pandemic.
Over the projected period, the Spirometer
market is likely to rise due to increased research and
development initiatives for the development of technologically sophisticated
spirometers. For example, the University of Illinois at Chicago completed a
phase III clinical trial research in partnership with the Agency for Healthcare
Research and Quality, a division of the US Department of Health and Human
Services, in September 2019. The use of a spirometer can help uncover
diagnostic mistake in patients with chronic obstructive pulmonary disease and
asthma, according to this clinical investigation.
Comments
Post a Comment